Diabetic retinopathy (DR) is a sight‐threatening complication of diabetes mellitus (DM) and it
contributes substantially to the burden of disease globally. During the last decades, the …

Various imaging modalities are of significant utility in the screening, grading, treatment, and
follow-up of the different stages of diabetic retinopathy (DR) and diabetic macular edema …

Background: Diabetic eye disease is the most common cause of blindness worldwide in the
population under 65 years of age. The prevalence of sight-threatening diabetic eye disease …

Advancement of imaging technology in retinal diseases provides us more precise
understanding and new insights into the diseases' pathologies. Diabetic retinopathy (DR) is …

Over the last decade, there has been an expansion of imaging modalities available to
clinicians to diagnose and monitor the treatment and progression of diabetic retinopathy …

Diabetic retinopathy and diabetic macular edema (DME) are leading causes of blindness
throughout the world, and cause significant visual morbidity. Ocular imaging has played a …

Rising prevalence of diabetes worldwide has necessitated the implementation of population-
based diabetic retinopathy (DR) screening programs that can perform retinal imaging and …

In this review, we describe the benefits and clinical applications of several imaging
techniques in diabetic retinopathy including color photography, fluorescein angiography …

Retinal imaging has been a key tool in the diagnosis, evaluation, management and
documentation of diabetic retinopathy (DR) and diabetic macular oedema (DMO) for many …

Diabetic retinal disease (DRD) remains a leading cause of vision loss and blindness
globally. Although treatments can be effective when given at vision-threatening stages of …